These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8266540)

  • 1. Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies.
    Torlone N; Piazza A; Valeri M; Tisone G; Poggi E; Provenzani L; Monaco PI; Adorno D; Casciani CU
    Transplant Proc; 1993 Dec; 25(6):3275-6. PubMed ID: 8266540
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal transplantation in highly sensitised recipients.
    Klouda PT; Rogers CA; Corbin SA; Bradley BA
    Transplant Proc; 1990 Aug; 22(4):1903. PubMed ID: 2202132
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cytotoxicity against donor HLA markers by posttransplant sera from renal allograft recipients.
    Gülay Z; Bora S; Kavukçu S; Mehr MA; Elverdi B; Gülay H
    Transplant Proc; 1995 Oct; 27(5):2683-4. PubMed ID: 7482874
    [No Abstract]   [Full Text] [Related]  

  • 6. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 8. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity in recipients prior to and post living kidney and liver transplantation.
    Lindemann M; Saure C; Klinkenbusch H; Valentin-Gamazo C; Horn PA; Cicinnati VR; Beckebaum S; Witzke O
    Scand J Immunol; 2011 Apr; 73(4):344-5. PubMed ID: 21223351
    [No Abstract]   [Full Text] [Related]  

  • 12. Recipient HLA-DR phenotypes influence survival of living-related donor renal allografts.
    Endo T; Watanabe K; Uchida H; Endo T; Okubo M; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):696-8. PubMed ID: 3274846
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the graft as a source of donor-type microchimerism in liver transplant patients.
    Hisanaga M; Schlitt HJ; Hundrieser J; Nakajima Y; Kanehiro H; Nakano H; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1073-5. PubMed ID: 8623231
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it time to prospectively match human leukocyte antigen proteins for lung transplantation?
    Neuringer IP; Aris RM
    Transplantation; 2010 Oct; 90(8):823-4. PubMed ID: 20697323
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant-induced donor-specific antibodies and graft outcome.
    Martin S; Dyer PA; Mallick NP; Gokal R; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):899-90. PubMed ID: 3274886
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological selection of donors and recipients in renal grafts: antibodies].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR oligotyping of 100 kidney transplant patients with difficult serological typing: correlation between serology and DNA typing.
    Tiercy JM; Goumaz C; Mach B; Jeannet M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):383-4. PubMed ID: 1990559
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
    Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.